Search Autoimmune Association
Share this article
Gettyimages A

Autoimmune Association Most Favored Nation Model (MFN) Statement of Concern

Gettyimages A X

The Autoimmune Association is greatly concerned that the Most Favored Nation Model (MFN) Interim Final Rule released by the Centers for Medicare and Medicaid (CMS) on November 20th and set to take effect later this month will limit access and threaten innovation to critical medicines for our nation’s most vulnerable patients. As proposed, the MFN Model would be mandatory, last for seven years, and initially affect 50 drugs reimbursed under Medicare Part B. Much like the International Pricing Index (IPI) and other structures floated previously, the MFN would adopt prices set by a group of foreign countries that have very different, often discriminatory models for health care that often deny or delay coverage for medicines currently available to Americans with autoimmune diseases. Autoimmune Association understands that these reference nations employ Quality Adjusted Life Years (QALYs) in their calculations for health care coverage, value and cost which is highly discriminatory towards people with chronic conditions and disabilities.

Autoimmune Association supports efforts to improve access and reduce costs for autoimmune patients and all Americans. But MFN implementation without the opportunity for full public comment and appropriate consideration of potential negative consequences on access to current and future life-changing therapies for Medicare Part B patients and others puts these groups at risk for managing their health. Autoimmune Association urges the Administration to immediately withdraw the MFN Model interim Final Rule to avoid importing a pricing structure that is incompatible with the American health care system, patient needs, and national values. From a patient perspective, the MFN Model is not an equitable, effective, nor viable approach for truly promoting health and well-being for those with autoimmune and other chronic conditions and disabilities. Thus, Autoimmune Association encourages alternative, U.S.-based strategies for achieving savings in health care spending.

Share this article

Join our email list

Receive the latest blog articles, news, and more right to your inbox!

Related articles you might be interested in

Autoimmune Association Image Do Not Touch

Meet Lesley Wilks: Pretty Sick

Lesley Wilks’ journey with autoimmune diseases has not been an easy one. To date, she has been diagnosed with three separate autoimmune diseases...
Autoimmune Association Image Do Not Touch

CMS Drops Stacking Provision in Medicaid Drug Rebate Proposal

  The Autoimmune Association, along with 31 other patient organizations, submitted a letter to request the Centers for Medicare & Medicaid Services (CMS)...
Autoimmune Association Image Do Not Touch

Raising Hope: The Joseph Coniglio Charity Golf Tournament

  Lucia Coniglio’s family has been significantly impacted by autoimmune disease. She lives with an autoimmune disease causing a narrowing of the esophagus,...
Autoimmune Association Image Do Not Touch

AMP AIM: Modeling relationships to establish breakthroughs in autoimmune health

  Autoimmune and immune-mediated diseases in the U.S. currently lack a centralized research strategy. Unlike cancer research, which consolidated under the National Cancer...

Find more resources on autoimmunity

Learn more about autoimmunity, diagnosis tips, how to find a physician, and more.